AI assistant
Indutrade — M&A Activity 2008
Mar 19, 2008
2927_rns_2008-03-19_e5440243-a1bb-4bb5-9849-5d027b097697.pdf
M&A Activity
Open in viewerOpens in your device viewer
Indutrade AB (publ) Box 6044, SE-164 06 Kista, Sweden Visitors' address: Raseborgsgatan 9 Phone: + 46 8 703 03 00 Fax: + 46 8 752 79 39 E-mail: [email protected] www.indutrade.se
Press release
Indutrade acquires med-tech company
Indutrade today acquired all of the shares in EssMed AB, in Mölnlycke, Sweden, with annual sales of approximately SEK 60 million.
EssMed markets ophthalmology products and services. The company is a market leader in sales of equipment to private and public sector ophthalmology departments. EssMed also sells other medical products, including operation microscopes and pressure relief devices. The company has a subsidiary in Finland.
The acquisition of EssMed marks the entry into a new product segment for Indutrade, in the pharmaceutical industry. Organisationally, EssMed will be included in the Industrial Components business area, which had net sales of SEK 940 million in 2007.
The acquisition is expected to have a marginally positive impact on Indutrade's earnings per share.
Stockholm, 19 March 2008
INDUTRADE AB (publ)
For further information, please contact: Johnny Alvarsson, President and CEO, tel. +46-70 589 17 95.
About Indutrade
Indutrade markets and sells components, systems and services with a high-tech content within selected niches. Indutrade's business is distinguished by
- High-tech products for recurring needs
- Growth through a structured and tried-and tested acquisition strategy
- A decentralised organisation characterised by an entrepreneurial spirit.
The Group is organised into four business areas: Engineering & Equipment, Flow Technology, Industrial Components and Special Products. Indutrade's sales totalled SEK 5,673 million in 2007, generating operating income of SEK 650 million before depreciation of intangible assets. Indutrade is listed on the OMX Nordic Exchange Stockholm.